Development of Modified Dosage Form for Enhancement of Dissolution Rate through Amalgamation of Solid Dispersion and Cube Sugar or Sintering Technology Using Famotidine as a Model Drug

References

1. 1.↵
   1. Banker G. S.,
   2. Rhodes C. T.

   1. Rudnic E. M.,
   2. Kottke M. K.

   Modern Pharmaceutics, 3rd ed.; Banker G. S., Rhodes C. T. Eds.; Marcel Dekker, Inc.: New York, 1999; p 333.
2. 2.↵
   1. Banakar U. V.

   Pharmaceutical Dissolution Testing; Marcel Dekker, Inc.: New York, 1992; Vol. 49, p 1.

   OpenUrl
3. 3.↵
   1. Ridolfo A. S.,
   2. Tompkins L.,
   3. Bechtol L. D.,
   4. Carmichael R. H.

   Benoxaprofen, a new anti-inflammatory agent: particle size effect on dissolution rate and oral absorption in humans. J. Pharm. Sci. 1979, 68 ( 7), 850– 852.

   OpenUrlPubMed
4. 4.↵
   1. Lerk C. F.,
   2. Lagas M.,
   3. Fell J. T.,
   4. Nauta P.

   Effect of hydrophilization of hydrophobic drugs on release rate from capsules. J. Pharm. Sci. 1978, 67 ( 7), 935– 939.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Khan K. A.

   Application of techniques for improving efficacy of solid dosage forms. Drug Dev. Ind. Pharm. 1981, 7, 421.

   OpenUrl
6. 6.↵
   1. Gupta M. K.,
   2. Tseng Y. C.,
   3. Goldman D.,
   4. Bogner R. H.

   Hydrogen bonding with adsorbent during storage governs drug dissolution from solid-dispersion granules. Pharm. Res. 2002, 19 ( 11), 1663– 1672.

   OpenUrlPubMed
7. 7.↵
   1. Bibby D. C.,
   2. Davies M. N.,
   3. Tucker I. G.

   Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. Int. J. Pharm. 2000, 197 ( 1–2), 1– 11.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Loftsson T.,
   2. Brewster M. E.

   Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stablization. J. Pharm. Sci. 1996, 85 ( 10), 1017– 1025.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Weuts I.,
   2. Kempen D.,
   3. Verreek G.,
   4. Decorte A.,
   5. Heymans K.,
   6. Peeters J.,
   7. Brewster M.,
   8. Van den Mooter G.

   Studies of the physicochemical properties and stability of solid dispersion of loperamide and PEG 6000 prepared by spray drying. Eur. J. Pharm. Biopharm. 2005, 59 ( 1), 119– 126.

   OpenUrlPubMed
10. 10.↵
    1. Te Wierik G. H.,
    2. Eissens A. C.,
    3. Besemer A. C.,
    4. Lerk C. F.

    Preparation, characterization and pharmaceutical application of linear dextrins. II. Complexation and dispersion of drugs with amylodextrin by freeze-drying and kneading. Pharm. Res. 1993, 10 ( 9), 1280– 1284.

    OpenUrlPubMed
11. 11.↵
    1. Breitenbach J.

    Melt extrusion: from process to drug delivery technology. Eur. J. Pharm. Biopharm. 2002, 54 ( 2), 107– 117.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Chiou W. L.,
    2. Riegelman S.

    Pharmaceutical application of solid dispersion systems. J. Pharm. Sci. 1971, 60 ( 9), 1281– 1302.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Ford J. L.

    The current status of solid dispersions. Pharm. Acta Helv. 1986, 61 ( 3), 69– 88.

    OpenUrlPubMed
14. 14.↵
    1. Leuner C.,
    2. Dressman J.

    Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 2000, 50 ( 1), 47– 60.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Serajuddin A. T.

    Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 1999, 88 ( 10), 1058– 1066.

    OpenUrlPubMed
16. 16.↵
    1. Banker G. S.,
    2. Rhodes C. T.

    1. Augsburger L. L.

    Modern Pharmaceutics, 3rd ed.; Banker G. S., Rhodes C. T. Eds.; Marcel Dekker, Inc.: New York, 1999; p 395.
17. 17.↵
    1. Barbara E.,
    2. Stephen H.,
    3. William R.

    Sugars. Ullmann's Encyclopedia of Industrial Chemistry, 5th ed; VCH Publication; Weinheim, Germany 1994; Vol. A25, p 345.

    OpenUrl
18. 18.↵
    1. Swarbric J.,
    2. Boylan J. C.

    1. Li L. C.,
    2. Li J. H.

    Encyclopedia of Pharmaceutical Technology; Swarbric J., Boylan J. C. Eds.; Marcel Dekker, Inc.: New York, 1996; Vol. 14., p 87.

    OpenUrl
19. 19.↵
    1. Perry R. H.,
    2. Green D. W.

    Perry's Chemical Engineers' Handbook, 7th ed., McGraw-Hill: New York, 1997; p 1233.
20. 20.↵
    1. Badger W. L.,
    2. Banchero J. T.

    Chapter 12. Filtration Introduction to Chemical Engineering; McGraw-Hill: New York, 1997; p 578.
21. 21.↵
    1. Lowenthal W.

    Disintegration of tablets. J. Pharm. Sci. 1972, 61 ( 11), 1695– 1711.

    OpenUrlPubMed
22. 22.↵
    1. Giron D.

    Contribution of thermal methods and related techniques to the rational development of pharmaceuticals—Part 1. Pharm. Sci. Technol. Today 1998, 1 ( 5), 191– 199.

    OpenUrl
23. 23.↵
    1. Sagdinc S.,
    2. Bayarý S.

    Experimental and theoretical infrared spectra of famotidine and its interaction with ofloxacin. J. Mol. Structure. 2005, 744, 369– 376.

    OpenUrl